Oramed pharmaceuticals inc. (ORMP)
Balance Sheet / TTM
Feb'20Nov'19Aug'19May'19Feb'19Nov'18Aug'18May'18Feb'18Nov'17Aug'17May'17Feb'17Nov'16Aug'16May'16Feb'16Nov'15Aug'15May'15Feb'15Nov'14Aug'14May'14Feb'14Nov'13Aug'13May'13Feb'13Nov'12Aug'12May'12Feb'12Nov'11Aug'11
ASSETS
CURRENT ASSETS:
Cash and cash equivalents

5,934

3,171

3,329

3,946

3,429

3,861

4,996

3,673

3,295

1,258

3,969

1,733

1,452

2,290

3,907

3,302

3,230

1,949

3,213

3,847

1,102

6,656

1,762

2,474

3,252

1,370

2,272

1,104

2,039

5,531

4,430

1,299

1,824

1,495

1,513

Short-term deposits

17,288

23,755

25,252

18,025

19,748

19,920

20,875

15,990

14,379

14,992

13,293

21,400

24,554

24,069

24,254

18,040

20,291

11,127

11,928

12,549

16,351

17,026

18,481

12,005

18,633

5,459

5,247

2,323

2,317

0

454

500

838

1,805

1,801

Marketable securities

5,704

3,207

3,701

4,223

5,474

5,143

4,592

3,710

3,229

2,722

2,860

3,072

3,607

3,690

2,855

3,363

2,081

1,984

2,088

758

695

688

1,047

1,063

1,464

962

956

803

987

1,064

200

357

341

380

384

Restricted cash

-

-

-

-

-

-

-

0

0

0

16

16

16

16

16

16

16

16

16

16

16

16

16

61

16

16

16

16

16

16

16

16

16

16

16

Prepaid expenses and other current assets

563

609

1,042

394

950

727

574

209

224

163

159

127

151

430

198

421

417

112

127

100

129

120

64

97

245

172

90

-

-

-

89

-

-

-

-

Related parties (note 13c)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

330

-

-

-

-

-

-

-

-

-

-

-

-

Grants receivable from the chief scientist

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

33

-

-

78

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable - other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

333

439

75

-

135

46

86

542

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

62

36

18

-

21

12

18

1

Related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

1

5

5

0

3

1

0

1

0

-

0

Grants receivable from the chief scientist

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

27

-

267

73

0

58

178

99

99

84

127

28

63

24

Total current assets

29,489

30,742

33,324

26,588

29,601

29,651

31,037

23,582

21,127

19,135

20,297

26,348

29,780

30,495

31,230

25,142

26,035

15,188

17,372

17,303

18,295

24,533

21,778

15,969

23,686

7,986

8,644

4,823

5,939

6,807

5,276

2,458

3,108

3,865

4,284

LONG-TERM ASSETS:
Long-term deposits

-

-

-

9,400

11,120

11,613

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term deposits and investment

-

-

-

-

-

-

-

-

-

-

-

-

11,005

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term deposits

1

1

1

-

-

-

13,542

8,752

13,788

17,780

16,232

12,005

-

14,057

11,043

10,601

10,555

8,051

8,022

4,806

4,665

5

3

6,508

4

4

5

9

9

9

8

9

9

11

10

Marketable securities

250

250

1,295

1,400

1,051

2,290

2,785

2,293

3,306

4,598

2,151

1,409

1,023

350

530

535

1,762

623

940

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Amounts funded in respect of employee rights upon retirement

17

16

19

17

17

16

16

15

15

14

14

-

-

-

11

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amounts funded in respect of employee rights upon retirement

-

-

-

-

-

-

-

-

-

-

-

13

12

11

-

10

9

9

9

8

7

7

7

6

6

5

5

7

6

5

4

4

17

14

14

Property and equipment, net

25

27

24

27

21

23

17

17

18

17

18

17

16

15

16

17

11

12

11

12

13

15

14

13

12

8

6

5

1

2

4

2

7

11

17

Operating lease right of use assets

99

106

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total long-term assets

392

400

1,339

10,844

12,209

13,942

16,360

11,077

17,127

22,409

18,415

13,444

12,056

14,433

11,600

11,163

12,337

8,695

8,982

-

-

-

24

-

-

-

-

-

-

-

-

-

-

-

-

Total assets

29,881

31,142

34,663

37,432

41,810

43,593

47,397

34,659

38,254

41,544

38,712

39,792

41,836

44,928

42,830

36,305

38,372

23,883

26,354

22,129

22,980

24,560

21,802

22,498

23,709

8,005

8,660

4,846

5,957

6,824

5,294

2,474

3,142

3,902

4,325

LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable and accrued expenses

2,377

1,796

2,541

2,474

2,346

2,982

2,058

3,143

2,156

2,599

2,716

2,526

2,424

2,237

1,411

646

829

768

953

731

570

795

926

447

302

621

434

398

422

287

597

308

534

357

375

Contract liabilities

-

-

-

2,703

2,703

1,131

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues

2,703

2,703

2,703

-

-

-

2,449

2,449

2,449

2,449

2,449

2,449

2,449

2,450

2,162

650

649

-

500

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Advance on account of license agreement (see note 1a1)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

500

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Payable to related parties

43

96

64

39

55

51

46

45

113

76

0

61

60

47

48

42

41

36

36

34

35

32

47

-

-

-

64

-

-

-

-

0

0

19

18

Operating lease liabilities

32

46

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Account payable with former shareholder

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

47

47

47

-

47

47

47

47

47

47

47

47

Total current liabilities

5,155

4,641

5,308

5,216

5,104

4,164

4,553

5,637

4,718

5,124

5,165

5,036

4,933

4,734

3,621

1,338

1,519

1,304

1,489

765

605

827

973

495

349

668

498

446

469

334

644

355

582

424

441

LONG-TERM LIABILITIES:
Contract liabilities

-

-

-

10,339

11,020

10,259

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenues

8,309

8,983

9,658

-

-

-

11,388

12,005

12,622

13,226

13,837

14,455

15,072

15,682

12,604

3,945

4,109

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrants (notes 6)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

637

-

-

-

0

Warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

Employee rights upon retirement

17

17

22

21

21

20

20

19

19

19

18

18

17

14

14

13

13

12

11

10

9

9

9

8

9

8

8

12

11

12

6

8

23

22

22

Provision for uncertain tax position

11

11

11

11

11

11

11

11

11

11

11

11

11

11

11

26

26

26

26

27

27

27

27

23

23

23

23

228

228

228

228

138

138

138

138

Operating lease liabilities

67

60

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

232

270

271

288

306

281

313

330

404

423

443

462

481

501

390

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total long-term liabilities

8,636

9,341

9,962

10,659

11,358

10,571

11,732

12,365

13,056

13,679

14,309

14,946

15,581

16,208

13,019

3,984

4,148

38

37

37

36

36

36

31

32

31

31

241

239

240

872

146

162

160

160

COMMITMENTS AND CONTINGENCIES (note 2)

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

STOCKHOLDERS' EQUITY:
Total liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

502

744

-

-

Common stock, $0.012 par value (30,000,000 authorized shares; 23,093,978 and 17,383,359 shares issued and outstanding as of February 29, 2020 and August 31, 2019, respectively)

214

209

208

207

207

207

207

172

171

170

163

159

159

158

157

157

157

138

138

129

129

129

121

119

117

95

95

86

86

86

80

70

70

70

70

Additional paid-in capital

103,210

100,597

100,288

100,173

99,892

99,701

99,426

82,584

81,939

80,871

75,170

72,954

72,787

72,437

71,943

-

71,578

59,693

59,184

53,971

53,463

53,191

48,040

47,574

46,726

30,123

29,856

25,273

24,993

24,778

21,589

18,446

18,339

18,277

18,201

Additional paid-in capital

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

71,768

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated other comprehensive income

-

-

-

-

-

-

702

198

313

727

401

497

211

43

106

314

230

152

558

163

100

93

452

467

846

334

304

131

244

235

0

15

-

-4

-

Accumulated deficit

-87,334

-83,646

-81,103

-78,823

-74,751

-71,050

-69,223

-66,297

-61,943

-59,027

-56,496

-53,800

-51,835

-48,652

-46,016

-41,256

-39,260

-37,442

-35,052

-32,936

-31,353

-29,716

-27,820

-26,190

-24,362

-23,247

-22,124

-21,332

-20,076

-18,850

-17,891

-16,561

-16,011

-15,025

-14,547

Total stockholders' equity

16,090

17,160

19,393

21,557

25,348

28,858

31,112

16,657

20,480

22,741

19,238

19,810

21,322

23,986

26,190

30,983

32,705

22,541

24,828

21,327

22,339

23,697

20,793

21,971

23,327

7,305

8,131

4,159

5,248

6,249

3,778

1,971

2,398

3,317

3,723

Total liabilities and stockholders' equity

29,881

31,142

34,663

37,432

41,810

43,593

47,397

34,659

38,254

41,544

38,712

39,792

41,836

44,928

42,830

36,305

38,372

23,883

26,354

22,129

22,980

24,560

21,802

22,498

23,709

8,005

8,660

4,846

5,957

6,824

5,294

2,474

3,142

3,902

4,325